High Expression of the Long Noncoding RNA SNHG15 in Cancer Tissue Samples Predicts an Unfavorable Prognosis of Cancer Patients: A Meta-Analysis

Figure 7

Validation of SNHG15 in the TCGA dataset. (a) Survival curves of SNHG15 are plotted for 9 kinds of cancers involved in this meta-analysis from the TCGA dataset. (b) Survival curves of SNHG15 are plotted for digestive cancers, including hepatocellular carcinoma (HCC), colorectal cancer (CRC), gastric cancer (GC), and pancreatic cancer (PC), from the TCGA dataset. (c) Survival curves of SNHG15 are plotted for other cancers, including renal cell cancer (RCC), thyroid cancer (TC), breast cancer (BC), and epithelial ovarian cancer (OC), from the TCGA dataset. (d) Survival curves of SNHG15 are plotted for non-small-cell lung cancer, including lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC), from the TCGA dataset.

(a)

(b)

(c)

(d)